Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metformin added to neoadjuvant chemoradiotherapy for rectal cancer
IRCT20190726044335N1Phase 2Completed
- Sponsor
- Shiraz University of Medical Sciences
- Start
- Aug 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, single-blind trial of metformin in rectal cancer and rectal adenocarcinoma (2 arms), sponsored by Shiraz University of Medical Sciences. Primary endpoint: Pathologic complete response. Started Aug 2019; status: completed.
02
Drugs
metformin
03
Conditions
rectal cancerrectal adenocarcinoma
Beyond the preview
Go deeper on IRCT20190726044335N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20190726044335N1.